Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donelly A van Schalkwyk

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 27, 2006
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparumDonelly A van Schalkwyk, Timothy J Egan
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2008
The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparumDonelly A van Schalkwyk, Waldemar Priebe, Kevin J Saliba
Antimicrobial Agents and Chemotherapy|October 23, 2019
Modification of <i>pfap2μ</i> and <i>pfubp1</i> Markedly Reduces Ring-Stage Susceptibility of Plasmodium falciparum to Artemisinin <i>In Vitro</i>Ryan C Henrici, Donelly A van Schalkwyk, Colin J Sutherland
International Journal for Parasitology. Drugs and Drug Resistance|January 2, 2019
Transient temperature fluctuations severely decrease P. falciparum susceptibility to artemisinin in vitroRyan C Henrici, Donelly A van Schalkwyk, Colin J Sutherland
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agentsDonelly A van Schalkwyk, Robert W Moon, Benjamin Blasco, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 27, 2021
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium speciesDonelly A van Schalkwyk, Robert W Moon, Maëlle Duffey, et al.
International Journal of Antimicrobial Agents|July 13, 2005
Reversal of chloroquine resistance in Plasmodium falciparum by 9H-xanthene derivativesChung-Pu Wu, Donelly A van Schalkwyk, Dale Taylor, et al.
Plos One|March 29, 2013
Loss of pH control in Plasmodium falciparum parasites subjected to oxidative stressDonelly A van Schalkwyk, Kevin J Saliba, Giancarlo A Biagini, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2011
Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRTAdele M Lehane, Donelly A van Schalkwyk, Stephanie G Valderramos, et al.
FEBS Letters|August 20, 2013
Studies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysisErick T Tjhin, Henry M Staines, Donelly A van Schalkwyk, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 27, 2006
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparumDonelly A van Schalkwyk, Timothy J Egan
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2008
The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparumDonelly A van Schalkwyk, Waldemar Priebe, Kevin J Saliba
Antimicrobial Agents and Chemotherapy|October 23, 2019
Modification of <i>pfap2μ</i> and <i>pfubp1</i> Markedly Reduces Ring-Stage Susceptibility of Plasmodium falciparum to Artemisinin <i>In Vitro</i>Ryan C Henrici, Donelly A van Schalkwyk, Colin J Sutherland
International Journal for Parasitology. Drugs and Drug Resistance|January 2, 2019
Transient temperature fluctuations severely decrease P. falciparum susceptibility to artemisinin in vitroRyan C Henrici, Donelly A van Schalkwyk, Colin J Sutherland
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agentsDonelly A van Schalkwyk, Robert W Moon, Benjamin Blasco, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 27, 2021
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium speciesDonelly A van Schalkwyk, Robert W Moon, Maëlle Duffey, et al.
International Journal of Antimicrobial Agents|July 13, 2005
Reversal of chloroquine resistance in Plasmodium falciparum by 9H-xanthene derivativesChung-Pu Wu, Donelly A van Schalkwyk, Dale Taylor, et al.
Plos One|March 29, 2013
Loss of pH control in Plasmodium falciparum parasites subjected to oxidative stressDonelly A van Schalkwyk, Kevin J Saliba, Giancarlo A Biagini, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2011
Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRTAdele M Lehane, Donelly A van Schalkwyk, Stephanie G Valderramos, et al.
FEBS Letters|August 20, 2013
Studies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysisErick T Tjhin, Henry M Staines, Donelly A van Schalkwyk, et al.
Pageof 4